Chair: Lars Krogvold

1. Prevention of type 1 diabetes – status and opportunities
Michael Knip, University of Helsinki and Helsinki University Hospital
2. Secondary prevention at onset of type 1 diabetes
    • DiVid Lars Krogvold, Oslo University Hospital
    • Azitromax-survey Frida Sundberg, The Queen Silvia Children’s Hospital, Gothenburg

10:30 Pause

Chair: Inger Njølstad

1. Healthy Choices and the social gradient – factors for health and risk of disease through the life course
Inger Njølstad, UiT The Arctic University of Norway
2. Incidence, prevalence and social inequalities in type 2 diabetes in Norway
Paz Lopez-Doriga Ruiz, Department for Chronic Diseases and Ageing, Norwegian Institute of Public Health
3. Type 2 diabetes in the Sami population. Results from the SAMINOR Study
Ann Ragnhild Broderstad, Centre for Sami Health Research, UiT The Arctic University of Norway, and University
Hospital of North Norway, Harstad
4. Trends in diabetes and treatment target achievement. The Tromsø-Study 1994–2016
Laila Hopstock, UiT The Arctic University of Norway

12:10 Pause

Chair: Helge Ræder

1. Gene editing and human stem cell based models of diabetes
Timo Otonkoski, University of Helsinki
2. Manipulating islet plasticity in order to cure diabetes
Simona Chera, UiB, University of Bergen, Geneva
3. Beta cell replacement therapy in the next ten years
Hanne Scholz, Oslo University Hospital

14:10 Pause

Chair: Marit Graue and Ane Wilhelmsen Langeland

1. Psychological impact of hypoglycemia
Frans Pouwer, University of Southern Denmark
2. Glucose variability and mood
Maartje de Wit, Amsterdam University Medical Center, Department of Medical Psychology
3. Hypoglycemia among older people in home care
Monica Herman, University of Western Norway

15:30 Pause

Chair: Kåre I. Birkeland

1. Cardiovascular risk and risk factor management beyond statins and antihypertensives
Naveed Sattar, University of Glasgow, Scotland
2. Atherosclerosis in diabetes – from bench to bedside
Kjetil Retterstøl, UiO University of Oslo
3. Should prevention of atherosclerosis in type 1 diabetes start in childhood?
Hanna Dis Margeirsdottir, Oslo University Hospital

17:10 Pause